Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Becton Dickinson & Co. recalls BD BBL Sensi Disc Tetracycline 30 ug

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
Products
  • BD BBL Sensi Disc Tetracycline 30 ug
Where it was sold

Domestic distribution nationwide. International distribution worldwide.

Nationwide

Barcodes
0038290230998730382902313442
Units affected
2,363,168 total units
About this recall
BD BBL Sensi Disc Tetracycline 30 ug,used for semi-quantitative in vitro susceptibility testing. Catalog Number 230998 and 231344¿